Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2004 2
2006 1
2007 1
2009 1
2011 1
2012 2
2018 2
2019 2
2020 2
2021 4
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.
Hussain M, Mateo J, Fizazi K, Saad F, Shore N, Sandhu S, Chi KN, Sartor O, Agarwal N, Olmos D, Thiery-Vuillemin A, Twardowski P, Roubaud G, Özgüroğlu M, Kang J, Burgents J, Gresty C, Corcoran C, Adelman CA, de Bono J; PROfound Trial Investigators. Hussain M, et al. N Engl J Med. 2020 Dec 10;383(24):2345-2357. doi: 10.1056/NEJMoa2022485. Epub 2020 Sep 20. N Engl J Med. 2020. PMID: 32955174 Free article. Clinical Trial.
Reply by Authors.
Guglielmetti GB, Dos Anjos GC, Sawczyn G, Rodrigues G, Cardili L, Cordeiro MD, Neves LCO, Pontes Junior J, Fazoli A, Coelho RF, Srougi M, Nahas WC. Guglielmetti GB, et al. Among authors: dos anjos gc. J Urol. 2022 Aug;208(2):267. doi: 10.1097/JU.0000000000002695.03. Epub 2022 May 24. J Urol. 2022. PMID: 35607900 No abstract available.
Pain and health-related quality of life with olaparib versus physician's choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open-label, randomised, phase 3 trial.
Thiery-Vuillemin A, de Bono J, Hussain M, Roubaud G, Procopio G, Shore N, Fizazi K, Dos Anjos G, Gravis G, Joung JY, Matsubara N, Castellano D, Degboe A, Gresty C, Kang J, Allen A, Poehlein C, Saad F. Thiery-Vuillemin A, et al. Among authors: dos anjos g. Lancet Oncol. 2022 Mar;23(3):393-405. doi: 10.1016/S1470-2045(22)00017-1. Epub 2022 Feb 11. Lancet Oncol. 2022. PMID: 35157830 Clinical Trial.
Impact of COVID-19 on a urology residency program.
Danilovic A, Torricelli FCM, Dos Anjos G, Cordeiro MD, Machado MG, Srougi M, Nahas WC. Danilovic A, et al. Among authors: dos anjos g. Int Braz J Urol. 2021 Mar-Apr;47(2):448-453. doi: 10.1590/S1677-5538.IBJU.2020.0707. Int Braz J Urol. 2021. PMID: 33284549 Free PMC article. No abstract available.
Aesthetic Contouring of the Chest wall with Rib Resection.
Ferreira LM, Ferreira PEN, Bernardes ABS, Dos Anjos GF, Cosac OM, Willhelm RO, Correa WEM, Felix GAA, Isoldi FC. Ferreira LM, et al. Among authors: dos anjos gf. Aesthetic Plast Surg. 2021 Jun;45(3):1099-1104. doi: 10.1007/s00266-020-01988-5. Epub 2020 Oct 9. Aesthetic Plast Surg. 2021. PMID: 33037473 Review.
Update on brow and forehead lifting.
Pedroza F, dos Anjos GC, Bedoya M, Rivera M. Pedroza F, et al. Among authors: dos anjos gc. Curr Opin Otolaryngol Head Neck Surg. 2006 Aug;14(4):283-8. doi: 10.1097/01.moo.0000233601.99423.cf. Curr Opin Otolaryngol Head Neck Surg. 2006. PMID: 16832187 Review.
Effect of re-ensiling on the quality of sorghum silage.
Dos Anjos GVS, Gonçalves LC, Rodrigues JAS, Keller KM, Coelho MM, Michel PHF, Ottoni D, Jayme DG. Dos Anjos GVS, et al. J Dairy Sci. 2018 Jul;101(7):6047-6054. doi: 10.3168/jds.2017-13687. Epub 2018 Mar 28. J Dairy Sci. 2018. PMID: 29605326 Free article.
23 results